跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Daiichi Sankyo Belgium
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2020
Approval ID
23b71cca4a9a574f
Company
Daiichi Sankyo Belgium
Type
Standard
Approval Details
Approval Id
23b71cca4a9a574f
Drug Cima Aemps Name
SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
BE387502
Holder Company Name
Daiichi Sankyo Belgium
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2020-06-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/10mg/25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Daiichi Sankyo Belgium
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
AMLODIPINO BESILATO
13,8 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2020
Approval ID
23b71cca4a9a574f
Type
Standard
Back to CIMA-AEMPS Approvals